BIBLIOGRAPHIC RECORD

Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects.

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Jason Younkin; Ajay H Bansode; Somdatta Saha; Archana Paymode; Jessica L Maltman; Charles B Jones; Justin M Silverman; Belle Buzzi; Alaina M Jaster; Michael Fiorillo; Jeremy Rolquin; George D Miller; Roya Abedi; Minho Kang; Maya Gaines-Smith; Enrique I Valenzuela Lesme; Mattias Embretsen; Jennifer T Wolstenholme; Richard A Glennon; Hamid I Akbarali; M Imad Damaj; I Scott Ramsey; Małgorzata Dukat; Javier González-Maeso
Source of metadata
PubMed
Year recorded
2026

Public identifiers and source

Open the source record

Reference

Jason Younkin; Ajay H Bansode; Somdatta Saha; Archana Paymode; Jessica L Maltman; Charles B Jones; Justin M Silverman; Belle Buzzi; Alaina M Jaster; Michael Fiorillo; Jeremy Rolquin; George D Miller; Roya Abedi; Minho Kang; Maya Gaines-Smith; Enrique I Valenzuela Lesme; Mattias Embretsen; Jennifer T Wolstenholme; Richard A Glennon; Hamid I Akbarali; M Imad Damaj; I Scott Ramsey; Małgorzata Dukat; Javier González-Maeso. (2026). Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects. https://pubmed.ncbi.nlm.nih.gov/42479815/

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-e36e9ecfc145409307bedde01693045a/